Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M214,501Revenue $M58,831Net Margin (%)15.6Z-Score3.2
Enterprise Value $M227,726EPS $3.7Operating Margin %18.5F-Score7
P/E(ttm))22.4Cash Flow Per Share $5.5Pre-tax Margin (%)18.3Higher ROA y-yY
Price/Book3.110-y EBITDA Growth Rate %4.9Quick Ratio1.0Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %2.3Current Ratio1.3Lower Leverage y-yN
Price/Cash Flow11.3y-y EBITDA Growth Rate %-16.9ROA % (ttm)7.3Higher Current Ratio y-yY
Dividend Yield %3.1Insider Buy (3m)0ROE % (ttm)12.3Less Shares Outstanding y-yY
Payout Ratio %73.0Shares Outstanding M2,447ROI % (ttm)10.2Gross Margin Increase y-yN

Gurus Latest Trades with NVS

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVSLee Ainslie 2014-03-31 Add0.1%$78.2 - $83.82
($81.23)
$ 88.419%Add 31.52%351,580
NVSPRIMECAP Management 2014-03-31 Reduce-0.26%$78.2 - $83.82
($81.23)
$ 88.419%Reduce -10.13%24,014,586
NVSLee Ainslie 2013-12-31 Reduce-0.56%$72.96 - $80.39
($77.55)
$ 88.4114%Reduce -66.76%267,321
NVSLee Ainslie 2013-06-30 Add0.2%$68.42 - $75.5
($72.61)
$ 88.4122%Add 39.5%741,689
NVSJohn Hussman 2013-06-30 Reduce-0.52%$68.42 - $75.5
($72.61)
$ 88.4122%Reduce -47.49%218,900
NVSVanguard Health Care Fund 2013-06-30 Sold Out -0.2%$68.42 - $75.5
($72.61)
$ 88.4122%Sold Out0
NVSLee Ainslie 2013-03-31 Buy 0.49%$63.3 - $71.32
($67.87)
$ 88.4130%New holding, 531689 sh.531,689
NVSVanguard Health Care Fund 2013-03-31 Reduce-0.71%$63.3 - $71.32
($67.87)
$ 88.4130%Reduce -85.39%726,200
NVSDodge & Cox 2012-12-31 Add0.11%$58.97 - $63.96
($61.79)
$ 88.4143%Add 2.65%48,438,459
NVSDodge & Cox 2012-09-30 Add0.12%$55.24 - $61.51
($58.49)
$ 88.4151%Add 3.23%47,187,759
NVSMario Gabelli 2012-03-31 Reduce$53.31 - $58.33
($52.37)
$ 88.4169%Reduce -37.42%11,740
NVSMichael Price 2012-03-31 Sold Out -1.3%$53.31 - $58.33
($52.37)
$ 88.4169%Sold Out0
NVSJohn Hussman 2012-03-31 Reduce-0.14%$53.31 - $58.33
($52.37)
$ 88.4169%Reduce -22.44%515,000
NVSMichael Price 2011-06-30 Buy 1.29%$54.23 - $64.52
($59.61)
$ 88.4148%New holding, 144969 sh.144,969
NVSVanguard Health Care Fund 2011-06-30 Add0.45%$54.23 - $64.52
($59.61)
$ 88.4148%Add 30.01%4,869,880
NVSMario Gabelli 2011-06-30 Add$54.23 - $64.52
($59.61)
$ 88.4148%Add 65.83%20,215
NVSMario Gabelli 2011-03-31 Reduce$52.75 - $59.24
($56.19)
$ 88.4157%Reduce -95.51%12,190
NVSVanguard Health Care Fund 2010-12-31 Reduce-0.42%$53.41 - $59.77
($57.3)
$ 88.4154%Reduce -21.07%4,869,880
NVSJohn Hussman 2010-12-31 Reduce-0.34%$53.41 - $59.77
($57.3)
$ 88.4154%Reduce -35.87%643,500
NVSMario Gabelli 2010-09-30 Buy 0.07%$47.85 - $58.09
($51.82)
$ 88.4171%New holding, 272290 sh.272,290
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
NVS Lee Ainslie 2014-03-31351,5800.010.42+31.52%
NVS John Hussman 2014-03-31221,2000.011.4
NVS Jean-Marie Eveillard 2014-03-3113,06000
NVS Dodge & Cox 2014-03-3146,441,1691.94-0.1%
NVS Tweedy Browne 2014-03-31291,5000.010.57-0.29%
NVS Mario Gabelli 2014-03-3110,74000-0.92%
NVS PRIMECAP Management 2014-03-3124,014,5860.982.3-10.13%
Premium Most recent portfolio changes are included for Premium Members only!


NVS: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about NVS :

    Quarterly/Annual Reports about NVS:

      News about NVS:

      Articles On GuruFocus.com
      Tweedy Browne Global Reports Their Second Quarter Portfolio Jul 18 2014 
      Sarah Ketterer’s Causeway International Value’s Top Five Holdings Jun 05 2014 
      Top Held European Stocks Highlighted by Health Care and Oil and Gas Stocks May 29 2014 
      Can Pfizer Make Up Its Loss? May 09 2014 
      These Three Pharmaceutical Companies Shake The Market With Their Deal Apr 27 2014 
      The Tweedy Browne Global Value Fund's Top First Quarter Holdings Apr 22 2014 
      PetMed Express Inc. Is Trying Harder to Push Sales Apr 21 2014 
      Diversification, Growth and Undervalued Stocks – Utilizing GuruFocus’ Global Gurus Apr 09 2014 
      Is Grifols Being Overlooked? Mar 19 2014 
      Top Held European Stocks Highlighted by Health Care and Oil and Gas Stocks Mar 12 2014 


      More From Other Websites
      FDA reviewing what could be first biosimilar drug Jul 24 2014
      2:56 am Novartis AG: FDA accepts Sandoz application for biosimilar filgrastim Jul 24 2014
      Top Biotechnology Stocks Jul 23 2014
      Anacor's Kerydin to Be Commercialized by Sandoz in the U.S. Jul 22 2014
      5 New Medical Technologies For Diabetics Jul 18 2014
      Novartis Misses on Q2 Earnings & Revenue, Outlook Retained Jul 18 2014
      Update: Google Teaming Up With Novartis To Develop Smart Lenses Jul 18 2014
      Novartis Joins Google To Develop Contacts For Diabetics Jul 18 2014
      [$$] Novartis Profit Creeps Higher Ahead of Revamp Jul 18 2014
      Why Novartis (NVS) Stock Is Down Today Jul 17 2014
      Novartis maintains forecasts despite weak quarter Jul 17 2014
      Novartis Splits the Difference Jul 17 2014
      [video] Novartis Misses Estimates as Vaccine Unit Slumps Jul 17 2014
      Novartis cites momentum in 3 percent profit rise Jul 17 2014

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Email Hide